1. Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis
   Ying Dong et al, 2023, Signal Transduction and Targeted Therapy CrossRef
2. The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4
   Wenjuan Zhang et al, 2022, Journal of Immunology Research CrossRef
3. A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States
   Namhee Kim et al, 2023, Cancer Research CrossRef
4. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis
   Martina Korfei et al, 2018, PLOS ONE CrossRef
5. Identification of YAP1 as a novel downstream effector of the FGF2/STAT3 pathway in the pathogenesis of renal tubulointerstitial fibrosis
   Xiaoying Li et al, 2021, Journal of Cellular Physiology CrossRef
6. Pirfenidone promotes the levels of exosomal miR-200 to down-regulate ZEB1 and represses the epithelial-mesenchymal transition of non-small cell lung cancer cells
   Jingjing Liu et al, 2022, Human Cell CrossRef
7. Pirfenidone inhibits motility of NSCLC cells by interfering with the urokinase system
   Matthias Krämer et al, 2020, Cellular Signalling CrossRef
8. Ethanol promotes alcohol-related colorectal cancer metastasis via the TGF-β/RUNX3/Snail axis by inducing TGF-β1 upregulation and RUNX3 cytoplasmic mislocalization
   Kehong Zheng et al, 2019, EBioMedicine CrossRef
9. Pirfenidone Sensitizes NCI-H460 Non-Small Cell Lung Cancer Cells to Paclitaxel and to a Combination of Paclitaxel with Carboplatin
   Helena Branco et al, 2022, International Journal of Molecular Sciences CrossRef
10. FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
    Jakub Szymczyk et al, 2021, Cancers CrossRef
11. Tumor microenvironment diversity and plasticity in cancer multidrug resistance
    Zhi Li et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
12. Modeling fibrotic alveolar transitional cells with pluripotent stem cell-derived alveolar organoids
    Victoria Ptasinski et al, 2023, Life Science Alliance CrossRef
13. Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
    Namrata Kewalramani et al, 2022, ERJ Open Research CrossRef
14. The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
    Jessica Lawrence et al, 2018, International Journal of Molecular Sciences CrossRef
15. Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis
    Cheng-Wei Huang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
16. Pirfenidone Reduces Epithelial–Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs)
    Hamidreza Aboulkheyr Es et al, 2021, Cancers CrossRef
17. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention
    Subhasmita Mahapatra et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
18. Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non–Small Cell Lung Cancer
    Edwin Roger Parra et al, 2020, Archives of Pathology & Laboratory Medicine CrossRef
19. Pirfenidone inhibits epithelial–mesenchymal transition in keloid keratinocytes
    Latha Satish et al, 2020, Burns & Trauma CrossRef
20. Antifibrotic Drugs for COVID-19: From Orphan Drugs to Blockbusters?
    Leander Corrie et al, 2021, Current Respiratory Medicine Reviews CrossRef
21. Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation
    Beatriz Ballester et al, 2020, Oncotarget CrossRef
22. Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway
    Hiroaki Ihara et al, 2020, Respiratory Investigation CrossRef
23. Molecular characterization of a precision-cut rat lung slice model for the evaluation of antifibrotic drugs
    Xinqiang Huang et al, 2019, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
24. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways
    Qun Lv et al, 2020, Molecular Medicine CrossRef